Eupraxia Pharmaceuticals EPRX Q1 2026 Earnings Clinical Progress Overshadows Slight EPS Miss DCTH Q1 2026 Earnings SmallerthanExpected Loss Despite No Reported Revenue Skye Bioscience Q1 2026 Earnings Wider Loss Than Expected as DevelopmentStage Biotech Continues Cash Burn BUD Q1 2026 Earnings EPS Beat Drives Stock Uptick Amid Cost Discipline Pyxis Oncology Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Reaction CLBT Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response